Holoclara, a biotechnology company pioneering the development of worm-derived therapies for allergies and autoimmune disorders, announced the completion of an oversubscribed $16 million Series...
Immunome, Inc., a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, announced the appointment of Phil Tsai, PhD, as Chief Technical...
Here is Read Magazine’s Weekly Roundup of the top news from global markets. In this fast-paced world, breaking down information helps readers grasp the...
AbbVie announced the acquisition of Celsius Therapeutics, Inc., a privately held biotechnology company pioneering new therapies for patients with inflammatory disease. Celsius' lead investigational...
RareCyte, Inc. a Life Sciences company providing advanced Precision Biology platforms including instruments, reagents, software, and services announced the completion of a $20M financing from...
